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The regulatory effects of lithium on the function of pertussis toxin-sensitive GTP-binding (C)-proteins located on the mitogenic pathway activated 
by insulin-like growth factor-1 (IGF-I) in FRTL-5 cells were studied. Addition of GTP-y-S to the thyroid stimulating hormone-primed cell 
membranes resulted in a decreased affinity of IGF-I receptor binding, and the dissociation constant (&) increased from 0.46 nM to 3.1 nM. 
Moreover, IGF-I stimulated GTP-y-S binding to a 40-kDa protein, and pertussis toxin (PT) attenuated the stimulatory effect of IGF-I on the same 
protein. Lithium lowered the affinity of IGF-I receptor binding and the Kd (3.4 nM) was in the same range as that in the presence of GTP-y-S. 
The inhibitory effect of lithium was markedly abolished by pretreatment with PT. Lithium attenuated the amounts of ADP-rebosylation of the 
40-kDa protein by PT. In addition, lithium stimulate Ca” entry, similar to that by IGF-I, and induced cell proliferation via a PT-sensitive step. 
These findings suggest hat lithium may be capable of modulating the function of G,-proteins coupled to IGF-I receptors during the G, phase of 
the FRTL-5 cell cycle. 
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1. INTRODUCTION 
Lithium, a monovalent cation, has been used thera- 
peutically for the treatment of manic-depressive disease 
and has a variety of biological effects on many tissues 
[ 1,2]. Moreover, the mitogenic effect of lithium has been 
reported on thyroid cells and fibroblasts [3,4]. The mod- 
ulation mechanism of cell proliferation induced by lith- 
ium, however, remains unknot. 
The activation of GTP-binding protein (G-protein)- 
mediated pathways in the appropriate phase of the cell 
cycle might promote the changes required for cell prolif- 
eration. Many growth factors and hormones bind to 
specific receptors that are coupled to G-proteins. Insu- 
lin-like growth factor-I (IGF-I) is capable of opening 
specific Ca”-channels via pertussis toxin (PT)-sensitive 
G-proteins (G,) but only in the G, phase of the cell cycle 
[5,6]. In addition, there is evidence that activating muta- 
tions of G-proteins can cause cell transformation [7]. On 
the other hand, lithium has the ability to affect G-pro- 
tein-dependent phenomena such as receptor-activated 
inositol lipid metabolism and adenylate cyclase activity 
WI. 
In this work, we examined whether the IGF-I recep- 
tor directly couples to Gi-proteins5 and further studied 
the effect of lithium on the G,-protein-coupled mito- 
Correspondence address: K. Takada, Department of Laboratory Med- 
icine, Osaka University Medical School l-l-50 Fukushima, Fu- 
kushima-ku, Osaka 553, Japan. Fax: (81) (6) 451-8742. 
genie system activated by IGF-I during the G1 phase of 
the rat thyroid (FRTL-5) cell cycle. 
2. MATERIALS AND METHODS 
2.1. Materials 
[‘*S]GTP-y-S, [4SCa]Cl, and [‘Hlthymidine were purchased from 
DuPont-New England Nuclear, GTP-y-S from Sigma Chemical Co., 
biosynthetic IGF-I, [‘251]IGF-I and [~z-~‘P]NAD from Amersham Co., 
pertussis toxin from Funakoshi Co. (Tokyo, Japan), and other mate- 
rials and culture medium were obtained from commercial sources. 
2.2. Cell culture 
FRTL-5 cells were maintained in Coon’s modified Ham’s F-12 
medium supplemented with 5% calf serum and six hormones (100 
flu/ml thyroid stimulating hormone (TSH), 10 ,ug/ml insulin, 5 &ml 
transferrin, 10 &ml somatostatin, 10 nM cortisone, and 10 ng/ml 
glycyl-r_-histidyl-L-lysine acetate) as described previously [lo]. In prep- 
aration for experiments, quiescent cells were obtained as follows: cells 
were incubated for 3 days in culture medium containing the six 
hormones and then for 2 days in hormone-free basal medium consist- 
ing of Ham’s F-12. TSH-primed (competent) cells were obtained as 
follows; quiescent cells were incubated for 6 h in Ham’s F-12 medium 
containing 100 pU/ml TSH and 0.25% BSA, and then washed three 
times with PBS. 
2.3. IGF-I binding assay 
TSH-primed cells were detached with 1 mM EDTA in saline as 
described [I I]. Cells were pelleted by ~nt~fu~ng at 1,000 x g for 10 
min, washed, resuspended in cold buffer containing SO mM Tris-HCI 
(pH 7.4), 1 mM EDTA, 0.25 M sucrose, 4 mM iodoacetic acid, ho- 
mogenized with a Dounce homogenizer, and centrifuged at 30,000 x g 
for 40 min. The resultant membrane pellet was resuspended inbinding 
buffer containing 100 mM HEPES-NaOH (pH 7.5), 120 mM NaCI, 
5 mM KCI, 1.2 mM MgSO,, 15 mM CH,CGONa, 1 mM EDTA, 10 
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mM dextrose, and 0.5% BSA. Aliquots containing 2Opg of membrane 
protein were incubated with 10 pM iodinated IGF-I in the presence 
and absence of unlabeled IGF-I at 37°C for 1 h. The membranes were 
washed in several volumes of cold buffer, and bound radioactivity was 
measured by a y-counter. Non-specific binding was determined in the 
presence of excess unlabeled IGF-I. Receptor number and affinity 
were estimated by Scatchard analysis according to the method de- 
scribed in [12]. 
2.4. ADP-ribosylation of membranes by pertussrs toxin (PT) 
Cell membranes were incubated in medium containing 50 mM Tris- 
HCl (pH 7.5) 1 mM EDTA, 10 mM dithiothreithol, 2 mM MgCIZ. 
10 mM thymidine, 1 mM ATP, 0.1 mM GTP, 10,~M [~z-~‘P]NAD, and 
10 pg/rnl PT at 30°C for 90 min. The reaction was terminated by the 
addition of 2 x SDS-PAGE sample buffer and immediate boiling. 
According to the method of Laemmli [13], proteins were electrophore- 
sed in acrylamide gels with SDS. To quantify incorporated [j2PJADP- 
ribose, a 40-kDa band was excised and radioactivity counted using a 
scintillation counter. 
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2.5. GTP-Y-S binding assay 
Membranes from TSH-primed cells were incubated with or without 
IGF-I in buffer containing 20 mM HEPES-NaOH (pH 7.4), 100 PM 
EDTA, 125 ,uM MgC&, and 100 nM [35S]GTP-y-S at 37°C for 15 min 
as described [14]. Incubations were terminated by adding ice-cold 
buffer containing 100 mM Tris-HCI (pH 8.0), 25 mM MgC&. 100 mM 
NaCl, and 20 PM GTP. The GTP-y-S binding to a 40-kDa protein 
was recovered by the gel filtration method [15], and radioactivity was 
counted in a liquid scmtillator. 
Fig. 1. Modulation of the IGF-I receptor binding by GTP-y-S. Mem- 
branes of TSH-primed FRTL-5 cells were incubated with [‘*51]IGF-I 
and increasing concentrations of unlabeled IGF-I in the presence (0) 
or absence (0) of 100 ,uM GTP-y-S. 
2.6. Measurement of Ca-‘+ entry 
Ca” entry was determined by measuring 45Ca uptake [16]. Cells 
were incubated for the indicated time in Ham’s F-12 medium contain- 
ing 0.25% BSA and with or without one or more of the following 
compounds; LiCl. IGF-I and PT. Cells were incubated at 37°C for 30, 
60, 90 or 120 s, and the reaction was terminated by aspirating the 
labeled medium. Cells were washed five times with ice-cold phosphate- 
buffered saline containing 25 mM MgCl,, and were lysed m 1 M 
NaOH, and the 4SCa content of the lysate was determined by liquid 
scintillation spectrometry. The rate of Ca’+ entry was calculated by 
using a slope of the linear regression line of Ca’+ uptake [6]. 
We next investigated the effect of lithium on G,-pro- 
teins coupled to the IGF-I receptor. Treatment with 
lithium, at therapeutic concentrations, decreased the af- 
finity of IGF-I receptor binding and increased the Kd 
value from 0.46 nM to 3.4 nM (Fig. 3A). The Kd value 
in the presence of 1 mM LiCl was in the same range as 
that in 100 ,uM GTP-y-S. We observed the effect of PT 
on the lithium action. Pretreatment with PT abolished 
the effect of lithium on IGF-I receptor binding (Fig. 
3B). Although the IGF-I receptor may be coupled to 
G,-proteins, treatment with PT had no effect on the 
affinity of IGF-I receptor binding. 
2.7. Measurement of cell proliferation 
Cell proliferation was assessed by [3H]thymidine incorporation, 
with or without one or more of the following agents; LiCl, IGF-I and 
PT. The reaction was stopped by addition of 10% trichloroacetic acid 
and the radioactivity in acid-insoluble material was counted in a liquid 
scintillation spectrometer. 
We examined the lithium action on ADP-ribosylation 
of G,-proteins by PT. Fig. 4 shows that lithium de- 
creased the amounts of ADP-ribosylation of G,-pro- 
teins in a dose-dependent manner. Addition of 1 mM 
LiCl to the assay medium caused an about 20% decrease 
in ADP-ribosylation of G,-proteins by PT compared 
with that in the absence of LiCl. 
3. RESULTS 
We studied the effect of GTP-y-S on IGF-I binding 
to the receptor in membranes from TSH-primed FRTL- 
5 cells. The addition of GTP-I/-S altered the dissociation 
constant (&) of IGF-I receptor binding from 0.46 nM 
to 3.1 nM (Fig. 1). We further examined whether the 
IGF-I receptor was coupled to PT-sensitive G-proteins 
(G,-proteins) in TSH-primed cells. Fig. 2 shows the ef- 
fect of PT on IGF-I-induced stimulation of GTP-y-S 
binding. IGF-I facilitated GTP-y-S binding to a 40-kDa 
protein. When membranes were pretreated with PT, the 
GTP-y-S binding to the 40-kDa protein by IGF-I was 
inhibited. These data demonstrate the direct coupling of 
the IGF-I receptor with G,-proteins in TSH-primed 
cells. 
We next studied the effect of lithium on the function 
of G,-proteins in mediating Ca*’ entry and cell cycle 
progression. As shown in Fig. 5, lithium, like IGF-I, 
markedly induced both sustained Ca2+ entry and DNA 
synthesis via the PT-sensitive pathway. 
4. DISCUSSION 
Conceivably, IGF-I receptors can be directly coupled 
to G,-proteins in TSH-primed FRTL-5 cells. The fol- 
lowing data support this conclusion; (i) the affinity of 
IGF-I binding to TSH-primed cell membranes was low- 
ered by the addition of GTP-y-S; (ii) IGF-I stimulates 
GTP-)/-S binding to the 40-kDa protein; (iii) treatment 
of membranes with PT attenuates the stimulatory effect 
of IGF-I on GTP-y-S binding to the 40-kDa protein; 
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Fig. 2. Effect of PT on IGF-I-induced stimulation of GTP-y-S bind- 
ing. Membranes were pretreated with (0) or without (0) 1 @ml PT 
for 2 h and then stimulated with increasing concentrations of IGF-I. 
(iv) PT abolishes IGF-I-mediated stimulation of Ca2+ 
entry and cell cycle progression. 
The present study provides evidence that one site of 
the action of lithium may be located on G,-proteins with 
which the IGF-I receptor interacts in TSH-primed 
FRTL-5 cells. Lithium lowered the affinity of the IGF-I 
receptor in a PT-sensitive manner in TSH-primed cells. 
Moreover, lithium attenuated the amounts of ADP-ri- 
bosylation of the 40-kDa protein by PT. In TSH-primed 
cells, lithium stimulated Ca2+ entry, similar to that by 
IGF-I, and induced cell cycle progression via a PT- 
sensitive step. Taking these data together, lithium con- 
ceivably may open the Ca2’-channel indirectly through 
functional modulation of Gi-proteins linked with the 
IGF-I receptor during the G, phase of the cell cycle. 
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Fig. 4. Effect of lithium on ADP-ribosylation of the 40-kDa protein 
by PT. Membranes were incubated with PT (10 @ml) in the presence 
of increasing concentrations of LiCl for 2 h. The ADP-ribosylation is 
expressed as a percentage of the control value obtained with cells 
cultured in the absence of LiCI. 
Further, Ca2’ entry stimulated by lithium, as well as by 
IGF-I, may be a mitogenic signal. 
Recently, an involvement of G-proteins in the action 
of lithium has been reported. Some studies have demon- 
strated that chronic lithium treatment results in a damp- 
ing of neurotransmitter agonist-stimulated inositol lipid 
hydrolysis and CAMP formation by perturbing G-pro- 
tein-receptor coupling [8,9]. TSH-stimulated CAMP 
generation is known to be decreased by lithium [17]. 
Moreover, lithium attenuates either Gpp(NH)p- or 
forskolin-induced activation of adenylate cyclase [ 181. 
Taken together, lithium may block the function of G- 
proteins. By contrast, lithium can activate the G,-pro- 
tein-associated Ca2’-channel in FRTL-5 cells, thereby 
inducing a mitogenic signal. Therefore, lithium might 
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Fig. 3. Effect of lithium on IGF-I receptor binding. (A) Membranes of TSH-primed cells were incubated with [“‘I]IGF-1 and increasing 
concentrations of IGF-I in the presence (0) or absence (0) of 1 mM LiCl. (B) Abolition of the lithium effect on IGF-I receptor binding. Membranes 
were pretreated with PT (1 @ml) for 2 h. Then, membranes were incubated with [‘r’I]IGF-I and increasing concentrations of IGF-I in the presence 
(0) or absence (0) of 1 mM LiCI. 
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Fig. 5. Inhibitory effect of PT on lithium-stimulated Ca2’ entry and 
DNA synthesis. TSH-primed cells were pretreated with (filled col- 
umns) or without (open columns) 1 &ml PT for 2 h. Then, cells were 
incubated with 1 mM LiCl or 1 nM IGF-I for 15 min and 42 h for 
measurement for, respectively, (A) Ca’+ influx and (B) DNA synthesis. 
Columns and bars in A and B represent the mean f SD. for triplicate 
determinations. 
have a dual action in the modulation of the function of 
G-proteins in mediating transmembrane signaling. 
With regard to the molecular basis of this action, it has 
been reported that lithium caused a conformational 
change of the G,-protein trimer without any dissocia- 
tion into its three subunits [19]. Presumably, lithium- 
induced conformational change may contribute to the 
alternation in the efficiency of IGF-I receptor interac- 
tion with Gi-proteins. Furthermore, it seems possible 
that lithium may activate the Ca2’-channel-associated 
mitogenic system through the conformational change of 
G,-proteins. 
In summary, lithium regulates the function of G,- 
proteins coupled to the IGF-I receptor during the G, 
phase of the rat thyroid cell cycle. In addition, lithium 
can stimulate the signal transduction pathway evoked 
by IGF-I via a modulation mechanism of G,-protein 
function. This effect may be involved, at least in part, 
in the regulation of thyroid cell cycle progression by 
lithium. 
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